Cas 136058-76-9,(5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone

136058-76-9

Post Buying Request

Basic information

Product Name: (5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone
Synonyms: (5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone
CAS NO:136058-76-9
Molecular Formula:
Molecular Weight: 388.261
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone(CAS DataBase Reference)
NIST Chemistry Reference: (5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone(136058-76-9)
EPA Substance Registry System: (5-Bromo-benzofuran-2-yl)-(2-cyclohexyl-5-methyl-oxazol-4-yl)-methanone(136058-76-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 136058-76-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

136058-76-9 Suppliers

Recommended suppliers

136058-76-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 136058-76-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,0,5 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 136058-76:
(8*1)+(7*3)+(6*6)+(5*0)+(4*5)+(3*8)+(2*7)+(1*6)=129
129 % 10 = 9
So 136058-76-9 is a valid CAS Registry Number.

136058-76-9Upstream product

1761-61-1 5-bromosalicyclaldehyde

136058-76-9Downstream Products

136058-63-4 5-[2-(2-Cyclohexyl-5-methyl-oxazol-4-ylmethyl)-benzofuran-5-ylmethyl]-oxazolidine-2,4-dione

136058-76-9Relevant academic research and scientific papers

Benzyloxazolidine-2,4-diones as potent hypoglycemic agents

Dow,Bechle,Chou,Clark,Hulin,Stevenson

, p. 1538 - 1544 (2007/10/02)

A series of benzyloxazolidine-2,4-diones, containing oxazole-based side chains, were found to lower blood glucose levels in the genetically obese ob/ob mouse. Incorporation of a benzofuran structural element in these compounds provides greatly enhanced in vivo potency. The syntheses and structure-activity relationships for this series are detailed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 136058-76-9